Cotiviti Holdings (NASDAQ: COTV) and NantHealth (NYSE:NH) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability.


This table compares Cotiviti Holdings and NantHealth’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cotiviti Holdings 12.58% 8.55% 4.19%
NantHealth -267.11% -83.97% -46.64%

Valuation & Earnings

This table compares Cotiviti Holdings and NantHealth’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Cotiviti Holdings $651.90 million 5.06 $222.12 million N/A N/A
NantHealth $98.18 million 3.30 -$116.13 million N/A N/A

Cotiviti Holdings has higher revenue and earnings than NantHealth.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Cotiviti Holdings and NantHealth, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cotiviti Holdings 0 3 5 0 2.63
NantHealth 0 0 4 0 3.00

Cotiviti Holdings presently has a consensus target price of $41.20, suggesting a potential upside of 15.15%. NantHealth has a consensus target price of $9.25, suggesting a potential upside of 247.74%. Given NantHealth’s stronger consensus rating and higher probable upside, analysts plainly believe NantHealth is more favorable than Cotiviti Holdings.


Cotiviti Holdings beats NantHealth on 7 of the 9 factors compared between the two stocks.

Cotiviti Holdings Company Profile

Cotiviti Holdings, Inc. is a provider of analytics-driven payment accuracy solutions. The Company focuses primarily on the healthcare sector. The Company operates through two segments: Healthcare, and Global Retail and Other. Through its Healthcare segment, the Company offers prospective and retrospective claims accuracy solutions to healthcare payers in the United States. The Company also provides analytics-based solutions unrelated to its healthcare payment accuracy solutions in the United States. Through its Global Retail and Other segment, the Company provides retrospective claims accuracy solutions to retailers primarily in the United States, Canada and the United Kingdom, as well as solutions that manage payment networks for a range of clients. The Company leverages its technology platform, configurable analytics, information assets and expertise in healthcare reimbursement to help its clients develop their claims payment accuracy.

NantHealth Company Profile

NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.

Receive News & Stock Ratings for Cotiviti Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti Holdings Inc and related stocks with our FREE daily email newsletter.